SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dabur India spurts even USFDA issues import alert on two of its plants at HP

14 Jun 2013 Evaluate

Dabur India is currently trading at Rs. 152.30, up by 1.85 points or 1.23% from its previous closing of Rs. 150.45 on the BSE.

The scrip opened at Rs. 151.50 and has touched a high and low of Rs. 153.90 and Rs. 144.90 respectively. So far 232044 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 165.70 on 13-May-2013 and a 52 week low of Rs. 106.80 on 20-Jun-2012.

Last one week high and low of the scrip stood at Rs. 158.95 and Rs. 147.65 respectively. The current market cap of the company is Rs. 26293.97 crore.

The promoters holding in the company stood at 68.66% while Institutions and Non-Institutions held 24.49% and 6.85% respectively.

The US Food and Administration (US FDA) has issued import alert on Dabur India’s two plants located in Baddi and Nalagarh in Himachal Pradesh. The company makes the original hygiene products like the Meswak toothpaste, while it makes skin care products like fairness cream bleach. The US FDA import alert means US authorities can detain without physical examination of new drugs promoted in the US.

Dabur India, however has clarified that it does not export products to the United States and so this import alert will not have any impact on its financials.

Dabur India is the fourth largest FMCG Company in India. Building on a legacy of quality and experience of over 125 years, Dabur operates in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care & Foods

Dabur India Share Price

473.35 -14.25 (-2.92%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2307.30
Godrej Consumer Prod 1010.55
Dabur India 473.35
Colgate Palmol. (I) 2137.15
P&G Hygiene 9889.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×